White matter abnormalities are well-established in adult patients with psychosis. Yet less is 29 known about changes in early onset psychosis (EOP) during adolescence, especially whether 30 antipsychotic medication might impact white matter microstructure in this sensitive phase. Here, 31
Introduction 55
A variety of hypotheses has been proposed to explain the etiology of psychotic disorders, 56
including aberrant dopamine neurotransmission 1 , altered neurodevelopmental trajectories 2 , 57 and active neuroinflammation 3 . Such theories are not mutually exclusive and are more likely 58 complementary. Patients with early onset psychosis (EOP), with defined age of onset before 59 18 years, provide an unprecedented opportunity to specifically investigate the perspective of 60 aberrant neurodevelopment. 61
The application of diffusion weighted imaging (DWI) can relate white matter organization to 62 disease. DWI maps the Brownian movement of water molecules in the brain in vivo, and as 63 axon membranes and myelin provide natural barriers for water diffusion, DWI can be used to 64 infer local tissue properties 4 . The most commonly used scalar measure is fractional anisotropy 65 (FA), which characterizes the degree of diffusion directionality. For an in-depth evaluation of 66 FA, the relative contribution of axial diffusion (AD) along the primary axis, and radial diffusion 67 (RD) perpendicular to it, can be informative. RD has been associated with changes in myelin 68 5 , and a disruption of myelin sheaths may be reflected in an increased RD. Conversely, AD 69 has been linked to axonal integrity and axonal damage may be characterized by decreased 70 AD 4 . 71
Using DWI, a number of studies show widespread FA reductions in many different brain 72 regions with low spatial overlap such as corpus callosum, cingulum, superior longitudinal 73 fasciculus, inferior longitudinal fasciculus and fronto-occipital fasciculus in EOP patients 74 compared to healthy controls 6-10 . Scalar DWI measures beyond FA are rarely analyzed in EOP 75 populations. However, Lagopoulos and colleagues report on increased RD values, indicative 76 of potential demyelinating processes underlying the observed white matter abnormalities 10 . 77
The low degree of regional specificity of whiter matter changes seems to be attributed to a 78 number of factors including differences in image acquisition, different analysis approaches 79 (ROI vs voxel-wise), small sample sizes, low prevalence of EOP (estimated prevalence of 17.6 80 in 10,000 at age of 18 years, 11 ) and differing sample characteristics such as age of onset. 81
Further, antipsychotic medication status might also affect the pattern of white matter 82 microstructure in EOP. 83
Studies investigating white matter microstructure in EOP mainly focus on case-control 84 differences, either reporting antipsychotic effects as secondary findings or using antipsychotic 85 medication status as a covariate of no interest. So far, studies in EOP patients do not indicate 86 an impact of either current [12] [13] [14] or cumulative antipsychotic exposure 6,13,15 on scalar DWI 87 measures. The absence of an antipsychotic medication effect could reflect small sample sizes 88 and young patients with shorter medication histories. The apparent limitations of the 89 adolescent study population also hold potential advantages: EOP patients are less affected by 90 chronic exposure to antipsychotic medication in comparison to their adult counterparts, which 91 allows for dissecting medication-mediated from disease-related effects on brain structure. 92
Furthermore, according to the World Health Organization guideline for pharmacological 93 interventions in adolescents with psychotic disorders (2015), antipsychotic medication use is 94 significantly less recommended in comparison to adult patients with psychosis 16 . This partly 95 translates to a clinical practice of a higher reluctance in starting antipsychotic treatment early 96 in the course of psychosis in children and adolescents, leading to a higher percentage of 97 antipsychotic-naïve EOP patients relative to adult first episode patients with psychosis. Thus, 98 EOP patients represent an ideal population to investigate the impact of antipsychotic 99 medication on white matter structure early in disease progression. 100
Here, we use a thoroughly clinically characterized adolescent EOP sample to (1) investigate 101 white matter microstructure in comparison to healthy controls, and (2) explore the association 102 between second-generation antipsychotic medication and white matter microstructure in 103 medicated compared to currently unmedicated/antipsychotic-naïve EOP patients. We utilize 104 DWI and, by using Tract-Based Spatial Statistics (TBSS), we calculate FA and its scalar sub- 
Demographic and clinical data 120
As presented in Table 1 , EOP patients did not differ significantly from controls in general 121 demographic variables such as age, handedness and IQ. However, there was a significant 122 case-control difference in clinical measures such as CGAS and MFQ, reflecting the clinical 123 diagnosis. EOP patients showed higher impairment of general functioning evaluated with 124 CGAS and exhibited significantly more depressive symptoms using MFQ, relative to their 125 healthy counterparts. Furthermore, patients report significantly more cannabis use than 126
controls. 127
Within the patient group (Table 2) , patients on antipsychotic medication were significantly older 128 than unmedicated patients (t = -4.186, p = 0.0006). In line with antipsychotic medication status, 129 duration of untreated psychosis (DUP) was significantly longer in the unmedicated EOP 130 subgroup in comparison to the medicated group. Further demographic and clinical variables 131 did not differ significantly between the patient subgroups. 132
TBSS analyses 133
Voxel-wise statistical analysis of case-control differences revealed decreases in mean FA 134
including the left genu of the corpus callosum, the left anterior corona radiata (ACR), and the 135 right superior longitudinal fasciculus (SLF) in EOP patients compared to healthy controls (see 136 Figure 1 and Table 3 ). There was no increase in mean FA for the opposing contrast. 137
Applying the TBSS pipeline to diffusion-derived data other than FA, namely RD and AD, did 138 not yield significant case-control differences for RD, but decreases in mean AD overlapping 139 with FA findings in EOP patients in comparison to healthy controls. In detail, mean AD shows 140 significantly decreases in the left ACR (see supplementary Table S2 ), in addition to decreases 141 in the right posterior limb of the internal capsule (PLIC) and right superior fronto-occipital 142 fasciculus (SFOF). 143
Extracted mean values of all scalar diffusion measures for all significant clusters stratified by 144 group are displayed in supplementary Figure S1 for descriptive purposes only. In the interest 145 of transparency, TBSS case-control differences in mean FA and mean AD (patients < controls) 146 at a cluster-forming threshold of p ≤ 0.05 are also presented (see supplementary Figure S2 ). 147
Linear regression analyses 148
To evaluate the potential influence of duration of illness and antipsychotic treatment on regional 149 mean FA and mean AD values within significant TBSS clusters, in patients, linear regression 150 analyses were performed. While duration of illness was not significantly associated with mean 151 FA in any of the clusters, we found a significant negative association with mean AD in the left 152 ACR (t = -2.364, p = 0.029). For latter association, however, the regression equation was not 153 significant (p = 0.085) and the overall explanatory power of the model was low (R 2 = 0.147), 154 rendering this finding most likely spurious (see supplementary Table S1 ). 155
Exposure to antipsychotic medication was significantly associated with mean FA values in the 156 left ACR (t = 2.991, p = 0.008), showing higher mean FA in medicated relative to the 157 unmedicated patients ( Figure 2 ). There was no association between antipsychotic medication 158 and mean FA or mean AD in the other significant TBSS clusters (see supplementary Table  159 S1). Cohen's d effect size values suggest a high (d = 1.48) and a low (d = -0.08) standardized 160 difference in mean FA of the left ACR in unmedicated and medicated EOP patients relative to 161 healthy controls, respectively ( Figure 3 ). Based on visual inspection, higher mean FA in 162 medicated patients seems driven by an increase in AD and a decrease in RD ( Figure 2 ). 163
However, mean AD and RD did not differ significantly between medicated and unmedicated 164 patients (Welch Two Sample t-test, AD: t = 0.183, p = 0.857; RD: t = 1.887, p = 0.079). 165
Association with clinical measures 166
We found no association between current antipsychotic medication evaluated as 167 chlorpromazine equivalent at scan day (CPZ, Spearman ρ = 0.13, n = 11, p = 0.695) or 168 cumulative CPZ (Pearson ρ = -0.15, n = 11, p = 0.665) with regional mean FA values in the 169 left ACR. 170
In addition, we also found no significant correlations, which survived correction for multiple 171 comparisons (FA cluster: Bonferroni, a = 0.003; AD cluster: Bonferroni, a = 0.004), between 172 neither extracted mean FA nor mean AD values of all significant TBSS clusters and clinical 173 measures such as PANSS (neither positive nor negative), CGAS and MFQ scores. Our case-control results replicate prominent brain regions with known white matter 179 abnormalities implicated in EOP, namely corpus callosum 6 , right SLF 14,17,18 and the left ACR 180 9,10 . Intriguingly, lower FA in these regions seems to occur early in the disease process 10,18,19 . 181
For instance, Lagopoulos and colleagues found a decrease in FA in the left ACR in both 182 patients with established psychiatric disorder and patients exhibiting sub-syndromal symptoms, 183 aged 14-30 years. Based on these findings, the authors proposed that abnormalities in the left 184 ACR are a putative precursor to the development of a psychiatric condition 10 . 185
However, the ACR is a highly heterogeneous structure with three long-range association fiber 186 tracts traversing through it 10 : anterior thalamic radiation (ATR), inferior fronto-occipital 187 fasciculus (IFOF) and uncinate fasciculus (UF). All three association fibers form connections 188 to the frontal lobe and have been implicated in the pathophysiology of psychiatric disorders 189 10,20-22 . In the current study, the left ACR peak voxel shows a 16% probability of IFOF year of treatment. In the current study, given that medicated EOP patients received either 234 aripiprazole, quetiapine or risperidone, one might speculate that early medication with second-235 generation antipsychotics might affect white matter microstructure by remediating 236 oligodendroglial dysfunction, leading to an increase in FA detected by DWI. 237
Even though FA is highly sensitive to microstructural changes in general, it lacks 238 neurobiological specificity to the exact type of change 4 . For instance, a decrease in FA can 239 reflect alternations in fiber organization, including packing density and fiber crossing, and 240 myelin loss or myelin remodeling 32 . We found a widespread decrease of AD on a whole brain 241 level, indicative of axonal damage, but no changes were found in RD, relative to healthy 242 controls. This finding is not in line with previous work from Lagopoulos and colleagues, who 243 found a decrease in FA in the left ACR associated with increases in RD and no changes in AD 244 10 . 245
Although there are likely several reasons for these conflicting findings, neuroinflammatory 246 processes might pose particular difficulties in interpreting DWI signals in psychotic populations 247 33 . For instance, in an animal model of cuprizone-induced demyelination of corpus callosum, 248 regions with extensive axonal edema and prominent cellular inflammation showed no change 249 in RD, while AD values were diminished at the beginning of demyelination 34 . Given the 250 neuroinflammation hypothesis of schizophrenia 3 , it seems likely that the disease progression 251 encompasses a dynamic evolution of inflammation, axonal injury, and myelin degeneration. In 252 the current study, one might speculate that EOP patients are on the verge of undergoing 253 demyelination processes, reflected by widespread decreases in AD. However, the timing of 254 neuroinflammation in psychotic disorders relative to tissue injury is unclear, leading to a 255 heightened risk of misinterpreting changes in DWI measures. According to a recent review of 256
Winklewski and colleagues, in cases of neuroinflammation linked to tissue damage, DWI 257 seems to underestimate the extent of demyelination (undervalued RD), and overestimate the 258 extent of axonal injury (overvalued AD) 35 . This pattern seems replicated in our study, with 259 significant changes in AD and no changes in RD. As the consistency of DWI metrics seems 260 affected by brain edema and inflammatory response, future studies can benefit from using 261 tools such as free water imaging which provide the opportunity to separate the contribution of 262 extracellular water from the diffusion of water molecules inside the fiber tracts, leading to a 263 higher specificity in detecting structural changes 36 . 264
Deviations in scalar DWI measures in the current study relative to previous studies could also 265 be due to ongoing white matter maturation processes in our adolescent EOP sample. In 266 healthy individuals, age-related increases in FA during childhood, adolescence and early 267 adulthood have been consistently reported 37-40 . This increase in FA seems primarily driven by 268 a reduction in RD, while AD remains fairly stable or decreases slightly 41,42 . Findings for AD 269 changes during the transition to adulthood are less consistent 37-40 . Thus, the AD difference 270 found in the current study could also be attributed to developmental processes, which may 271 fade as adolescents mature into adulthood. 272
However, it should be noted that the neurodevelopmental trajectories of white matter structure 273 relative to disease progression in EOP patients are unclear. So far, three different studies 274 yielded inconclusive results, postulating either diverging 13 , converging 43 , or parallel 44 275 trajectories relative to healthy controls. In the current study, we did not find any predictive value 276 of duration of illness for regional FA. This is in line with previous findings from Kumra and 277 colleagues, who speculated that the decrease in FA in EOP patients compared to healthy 278 controls reflects developmental abnormalities rather than secondary effects of the disease 279 progression 13 . In addition, Epstein and Kumra found lower FA in the inferior longitudinal 280 fasciculus, IFOF and corticospinal tract, but no significant group differences in longitudinal 281 changes in FA 44 . Thus, the observed changes in the current study might persist but do not 282 affect the overall white matter maturation trajectories. However, the cross-sectional nature of 283 the current study precludes the assessment of developmental effects over time. 284
The results of the current study should be considered in the context of several limitations. 285
Unmedicated EOP patients were significantly younger than those receiving medication. 286
Although the analysis was corrected for age, we cannot exclude that the age of the patients 287 contributes to the observed antipsychotic-medication related changes in white matter structure. 288
It is possible that time-of-measurement effects, with older patients having higher FA values 289 than younger patients due to more advanced white matter maturation, could confound our 290 results. However, while we acknowledge this possibility, we consider this unlikely to be the 291 driving mechanism for the following reason: we would expect differences in FA values in other 292
regions showing a similar maturation trajectory, such as the SLF 41 , if our results were mainly 293 driven by age differences. This was not the case, as we found no significant difference in mean 294 FA values of the SLF between medicated and unmedicated patients (t = -0.56934, p-value = 295 0.576). We further stress that we did not find any associations between regional FA variation 296
and clinical measures such a PANSS scores, which is likely due to the relatively small sample 297
size. 298
In summary, the present study is the first to link antipsychotic medication status to altered Healthy controls were randomly selected from the Norwegian National Registry in the same 318 catchment area. All participants and their respective parents/guardians provided written 319 informed consent. The study was approved by the Regional Committee for Medical Research 320
Ethics (REK-Sør) and the Norwegian Data Inspectorate and was conducted in accordance 321 with the Declaration of Helsinki. 322
For study inclusion, participants were required to have an intelligence quotient (IQ) > 70, a 323 good command of the Norwegian language, no previous moderate to severe head injuries, no 324 diagnosis of substance-induced psychotic disorder, and no organic brain disease. Table 1 and Table 2 , respectively. 339
Clinical measures 340
Presence and severity of psychopathological symptoms of EOP patients were assessed using 341 the Positive and Negative Syndrome Scale (PANSS 47 ). Children Global Assessment Scale 342 (CGAS 48 ) and Mood and Feelings Questionnaire (MFQ, long version 49 ) were evaluated in all 343 participants to measure general functioning level and to screen for depressive symptoms, 344 respectively. Recreational drug use was assessed within the structured K-SADS interview and 345 scored with 0 or 1 for absent or present. For EOP patients, current and lifetime cumulative use 346 of medication was recorded and converted into chlorpromazine equivalents (CPZ), using 347 formulas published elsewhere 50 . While 11 EOP patients were off any antipsychotic medication 348 at scan, yielding a lack of current CPZ values, 3 patients had received pharmacological 349 treatment prior to inclusion, resulting in a low cumulative CPZ dosage for this subgroup (see 350 Table 2) . 
Statistical analyses 378
For contrasting case-control differences, we run voxel-wise statistics, co-varied for age and 379 gender, using a nonparametric permutation-based approach (Randomise, implemented in FSL, 380 5000 permutations). All variables were demeaned. The statistical threshold was set at p ≤ 0.01, 381 after family-wise error correction for multiple comparisons using threshold-free cluster 382 enhancement. We chose a highly conservative threshold for FA to minimize type I errors and 383 to better account for the exploratory nature of the study concerning the impact of antipsychotic 384 medication status. For RD and AD, the same statistical model was used. 385
Regions identified with TBSS (FA) and TBSS non-FA (RD or AD were subsequently used as 386 masks to extract mean FA, RD and AD values for plotting and further analysis. We refrained 387 from using MD values, as a measure of overall diffusivity within a voxel, in further analysis due 388 to its lack of specificity 4 . As scalar diffusion measures largely vary in their value ranges, 389
extracted mean values were z-standardized for plotting purposes using the following formula: If there is an association between patients' regional mean values and antipsychotic medication, 396 follow-up correlation analysis with current and cumulative CPZ were performed using 397
Spearman's rank correlation rho for non-normal data. 398
Further analysis of regional mean values and its association with clinical measures (PANSS, 399 CGAS, MFQ) were performed using Pearson's product moment correlation coefficient. 400
Statistical tests were conducted in R, version 3.5.2 (www.r-project.org). 
